Moneycontrol
Last Updated : Nov 29, 2018 04:35 PM IST | Source: Moneycontrol.com

Reporter's Take | Sun Pharma stock dives to 6-month low amid cloud over corporate governance

M Saraswathy gets in conversation with Moneycontrol's Viswanath Pilla to discuss the implications of Macquarie note, Sun Pharma's response to the accusations, the future of the company and much more.

Moneycontrol News @moneycontrolcom

Sun Pharma stock fell around 9 percent from early this week. Now questions are raised over corporate governance practices at India's largest drug maker

Brokerage firm Macquarie questioned corporate governance practices in Sun Pharmaceutical Industries, causing the drugmaker's shares to end at a six-month low on November 29​

M Saraswathy gets in conversation with Moneycontrol's Viswanath Pilla to discuss the implications of the Macquarie note, Sun Pharma's response to the accusations, the future of the company and much more.

Watch the video for more...
First Published on Nov 29, 2018 04:33 pm
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant